COVID-19 vaccine effectiveness in patients with cancer: remaining vulnerabilities and uncertainties.
Publication
, Journal Article
Kuderer, NM; Lyman, GH
Published in: Lancet Oncol
June 2022
Duke Scholars
Published In
Lancet Oncol
DOI
EISSN
1474-5488
Publication Date
June 2022
Volume
23
Issue
6
Start / End Page
693 / 695
Location
England
Related Subject Headings
- Vaccine Efficacy
- Uncertainty
- Oncology & Carcinogenesis
- Neoplasms
- Humans
- COVID-19 Vaccines
- COVID-19
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Kuderer, N. M., & Lyman, G. H. (2022). COVID-19 vaccine effectiveness in patients with cancer: remaining vulnerabilities and uncertainties. Lancet Oncol, 23(6), 693–695. https://doi.org/10.1016/S1470-2045(22)00252-2
Kuderer, Nicole M., and Gary H. Lyman. “COVID-19 vaccine effectiveness in patients with cancer: remaining vulnerabilities and uncertainties.” Lancet Oncol 23, no. 6 (June 2022): 693–95. https://doi.org/10.1016/S1470-2045(22)00252-2.
Kuderer NM, Lyman GH. COVID-19 vaccine effectiveness in patients with cancer: remaining vulnerabilities and uncertainties. Lancet Oncol. 2022 Jun;23(6):693–5.
Kuderer, Nicole M., and Gary H. Lyman. “COVID-19 vaccine effectiveness in patients with cancer: remaining vulnerabilities and uncertainties.” Lancet Oncol, vol. 23, no. 6, June 2022, pp. 693–95. Pubmed, doi:10.1016/S1470-2045(22)00252-2.
Kuderer NM, Lyman GH. COVID-19 vaccine effectiveness in patients with cancer: remaining vulnerabilities and uncertainties. Lancet Oncol. 2022 Jun;23(6):693–695.
Published In
Lancet Oncol
DOI
EISSN
1474-5488
Publication Date
June 2022
Volume
23
Issue
6
Start / End Page
693 / 695
Location
England
Related Subject Headings
- Vaccine Efficacy
- Uncertainty
- Oncology & Carcinogenesis
- Neoplasms
- Humans
- COVID-19 Vaccines
- COVID-19
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis